| 引用本文：王贤吉,付晨,金春林,等.医药分开的内涵与实现途径探讨[J].中国卫生政策研究,2013,6(1):36-39 |
|
| 医药分开的内涵与实现途径探讨 |
| 投稿时间：2012-11-20 修订日期：2012-12-24 PDF全文浏览 HTML全文浏览 |
| 王贤吉1, 付晨2, 金春林3, 晏波2, 彭玉梅2, 陈小丽2, 陈卓蕾2 |
| 1.上海市卫生发展研究中心，复旦大学公共卫生学院;2.上海市卫生局;3.上海市卫生发展研究中心 |
| 摘要:本文围绕什么是医药分开和如何实现医药分开进行探讨，提出医药分开的核心是切断公立医院、医生与药品之间的利益纽带；取消药品加成不等于医药分开，但它是医药分开的必要措施，且现阶段取消药品加成对于打破我国公立医院改革的僵局而言有重要意义；“医”和“药”的真正分开不仅要在补偿机制上下功夫，还需要同步推进药品价格形成机制、公立医院监管考核机制和运行机制等方面的综合改革。 |
| 关键词:公立医院 医药分开 药品加成 |
| 基金项目:上海市卫生系统优秀青年人才培养计划项目（XYQ2011052） |
|
| Separating drug sales from medical services: Connotations and approaches |
|
|
| Abstract:In this paper, we focus on what it means to separate drug sales from medical services and how to realize this separation We suggest that separating drug sales from medical services involves cutting the interest ties among public hospitals, doctors, and drug manufacturers and suppliers Scrapping the drug markup in public hospitals does not in itself separate medical services from drug sales; however, it is an essential first step in public hospital reform in China Completing this separation relies not only on reforming compensation mechanisms, but also reforming supervision and assessment, pricing, and operational mechanisms |
| Key words:Public hospitals Sepatating drug sales from medical service Drug markup |
| 摘要点击次数: 4090 全文下载次数: 3135 |
|
|
